Treatment of brucellosis: A systematic review of studies in recent twenty years

Caspian Journal of Internal Medicine

Volumn 4, Issue 2, 2013, Pages 636-641

  Alavi, Seyed Mohammad ^a   Alavi, Leila ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Brucellosis; Doxycycline; Relapse; Streptomycin; Treatment

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; GENTAMICIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE;

BRUCELLOSIS; CLINICAL TRIAL (TOPIC); COMBINATION CHEMOTHERAPY; COMPARATIVE EFFECTIVENESS; DRUG EFFICACY; DRUG TREATMENT FAILURE; HUMAN; MONOTHERAPY; RELAPSE; REVIEW; SPONDYLITIS; SYSTEMATIC REVIEW; TIME SERIES ANALYSIS; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 84878978216     PISSN: 20086164     EISSN: 20086172     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis 2006; 6: 91-9.
2. Corbel MJ. Brucellosis: an overview. Emerg Infect Dis 1997; 3: 213-21.
3. Memish ZA, Balkhy HH. Brucellosis and international travel. J Travel Med 2004; 11: 49-55.
4. Pappas G, Memish ZA. Brucellosis in Middle East: A persistent medical, socioeconomic and political issue. J Chemother 2007; 19: 243-8.
5. Alavi SM, Rafiei A, Nikkhooi AR. The effect of lifestyle on brucellosis among nomads in Iran, Ahvaz. Pak J Med Sci 2007; 23: 358-60.
6. Alavi SM, Alavi L. Comparative study of current diagnostic method with clinical based method for brucellosis: presentation of diagnostic clinical criteria in limited resource area. Jundishapur J Microbiol 2010; 3: 121-4.
7. Pappas G, Aknitidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med 2005; 352: 2325-36.
8. Alavi SM, Motlagh ME, A Review of Epidemiology, Diagnosis and Management of Brucellosis for General Physicians Working in the Iranian Health Network. Jundishapur J Microbiol 2012; 5: 384-7.
9. Joint FAO/WHO expert committee on brucellosis. World Health Organ Tech Rep Ser 1986; 740: 1-132.
10. Young EJ. Brucella species. In: Mandel GI, Bonnet JE, Dolin R, (eds), Principle and practice of infectious disease. 7th ed. New York: Churchill Livingstone 2010; pp: 2921-25.
11. Solís Garcia Del Pozo J, Solera J. Systematic Review and Meta-Analysis of Randomized Clinical Trials in the Treatment of Human Brucellosis. PLoS ONE 2012; 7: e32090.
12. Solera J, Martinez-Alfaro E, Espinosa A, et al. Multivariate model for predicting relapse in human brucellosis. J Infect 1998; 36: 85-92.
13. Alavi SM, Alavi SMR, Alavi L. Relapsed human brucellosis and related risk factors. Pak J Med Sci 2009; 25: 28-34.
14. Ariza J, Bosilkovski M, Cascio A, et al. Prespectives for the treatment of brucellosis in the 21st century. The Loannina recommendations. PloS Med 2007; 4: e317.
15. Pappas G, Seitaridis S, Akritidis N, Tsianos E. Treatment of brucella spondylitis: lessons from an impossible meta-analysis and initial report of efficacy of a luoroquinolonecontaining regimen. Int J Antimicrob Agents 2004; 24: 502-7.
16. Kantatzi K, Panagoutsos S, Kokkinou V, et al. Brucellosis in dialysis patients. Does it exist? Clin Nephrol 2010; 73: 309-13.
17. Roushan MR, Gangi SM, Ahmadi SA. Comparison of the efficacy of two months of treatment with co-trimoxazole plus doxycycline vs. co-trimoxazole plus rifampin in brucellosis. Swiss Med Wkly 2004; 134: 564-8.
18. Hasanjani Roushan MR, Mohraz M, Hajiahmadi M, Ramzani A, Valayati AA. Efficacy of gentamicin plus doxycycline versus streptomycin plus doxycycline in the treatment of brucellosis in humans. Clin Infect Dis 2006; 42: 1075-80.
19. Hashemi SH, Gachkar L, Keramat F, et al. Comparison of doxycycline-streptomycin, doxycycline-rifampin, and ofloxacin-rifampin in the treatment of brucellosis: a randomized clinical trial. Int J Infect Dis 2012; 16: e247-51.
20. Keramat F, Ranjbar M, Mamani M, Hashemi SH, Zeraati F. A comparative trial of three therapeutic regimens: ciprofloxacin-rifampin, ciprofloxacin-doxycycline an doxycycline-rifampin in the treatment of brucellosis. Trop Doct 2009; 39: 207-10.
21. Alavi SM, Rajabzadeh AR. Comparison of two chemotherapy regimen: Doxycyclin-rifampicin and doxycycline cotrimoxazole in the brucellosis Patients, Ahvaz, Iran. Pak J Med Sci 2008; 23: 889-92.
22. Solera J, Rodríguez-Zapata M, Geijo P, et al. Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas. Antimicrob Agents Chemother 1995; 39: 2061-7.
23. Bayindir Y, Sonmez E, Aladag A, Buyukberber N. Comparison of five antimicrobial regimens for the treatment of brucellar spondylitis: a prospective, randomized study. J Chemother 2003; 15: 466-71.
24. Roushan MR, Soleimani Amiri MJ, Janmohammadi N, et al. Comparison of the efficacy of gentamicin for 5 days plus doxycycline for 8 weeks versus streptomycin for 2 weeks plus doxycycline for 45 days in the treatment of human brucellosis: a randomized clinical trial. J Antimicrob Chemother 2010; 65: 1028-35.
25. Ersoy Y, Sonmez E, Tevfik MR, But AD. Comparison of three different combination therapies in the treatment of human brucellosis. Trop Doct 2005; 35: 210-12.
26. Akova M, Uzun O, Akalin HE, Hayran M, Unal S, Gur D. Quinolones in treatment of human brucellosis: comparative trial of ofloxacin-rifampin versus doxycycline-rifampin. Antimicrob Agents Chemother 1993; 37: 1831-4.
27. Ranjbar M, Keramat F, Mamani M, et al. Comparison between doxycycline-rifampin-amikacin and doxycycline-rifampin regimens in the treatment of brucellosis. Int J Infect Dis 2007; 11: 152-6.
28. Karabay O, Sencan I, Kayas D, Sahin I. Ofloxacin plus rifampicin versus doxycycline plus rifampin in the treatment of brucellosis: a randomized clinical trial. [ISRCTN 11871179] BMC Infect Dis 2004; 4: 18.
29. Agalar C, Usubutun S, Turkyilmaz R. Ciprofloxacin and Rifampicin versus Doxycycline and Rifampicin in the Treatment of Brucellosis. Eur J Clin Microbiol Infect Dis 1999; 18; 535-8.
30. Solera J, Espinosa A, Martinez-Alfaro E, et al. Treatment of human brucellosis with doxycycline and gentamicin. Antimicrob Agents Chemother 1997; 41: 80-4.
31. Khuri-Bulos NA, Daoud AH, Azab SM. Treatment of childhood brucellosis: results of a prospective trial on 113 children. Pediatr Infect Dis J 1993; 12: 377-81.
32. Alp E, Koc RK, Durak AC, et al. Doxycycline plus streptomycin versus ciprofloxacin plus rifampicin in spinal brucellosis. [ISRCTN 31053647] BMC Infect Dis 2006; 6: 72.
33. Skalsky K, Yahav D, Bishara J, et al. Treatment of human brucellosis: systematic review and meta-analysis of randomized controlled trials. BMJ 2008; 336: 701-4.
34. Al-Hajjaj MS, Al-Kassimi FA, Al-Mobeireek AF, Alzeer AH. Mycobacterium tuberculosis resistance to rifampicin and streptomycin in Riyadth, Saudi Arabia. Respirology 2001; 6: 317-22.
35. Acocella G, Bertrand A, Beytour J, et al. Comparison of three different regimens in the treatment of acute brucellosis: a multicenter multinational study. J Antimicrobial Chemotherapy 1989; 23: 433-9.
36. Roushan MR, Mohraz M, Janmohammadi N, Hajiahmadi M. Efficacy of cotrimoxazole and rifampin for 6 or 8 weeks of therapy in childhood brucellosis. Pediatr Infect Dis J 2006; 6: 544-5.
37. Roushan MR, Amiri MJ Update on Childhood Brucellosis. Recent Pat Antiinfect Drug Discov 2012 Epub ahead of print]
38. Roushan MR, Ahmadi SA, Gangi SM, Janmohammadi N, Amiri MJ. Childhood brucellosis in Babol, Iran. Trop Doct 2005; 35: 229-31.